Table 3.
Independent prognostic factors by multivariate analyses
| Endpoint | Factor | P value | HR(95%CI) |
|---|---|---|---|
| OS | Age (≤50/>50) | 0.004 | 2.263 (1.306-3.920) |
| KPS (90/100 and 70/80) | 0.469 | 1.221 (0.712-2.095) | |
| T stage (T1/T2) | 0.519 | 1.215 (0.672-2.195) | |
| N stage (N0-1/N2-3) | 0.000 | 3.364 (1.862-6.078) | |
| RC | KPS (90/100 and 70/80) | 0.288 | 1.619 (0.666-3.938) |
| T stage (T1/T2) | 0.207 | 2.215 (0.645-7.606) | |
| N stage (N0-1/N2-3) | 0.005 | 25.940 (2.676-251.454) | |
| Chemotherapy (IC ± CCRT or AC) (no/yes) | 0.692 | 0.632 (0.065-6.109) | |
| DMFS | Gender (Male/Female) | 0.113 | 0.463 (0.179-1.198) |
| KPS (90/100 and 70/80) | 0.008 | 2.744 (1.306-5.765) | |
| N stage (N0-1/N2-3) | 0.001 | 6.170 (2.104-18.094) | |
| Chemotherapy (IC ± CCRT or AC) (no/yes) | 0.822 | 1.206 (0.237-6.122) |